Related references
Note: Only part of the references are listed.Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: a network meta-analysis and regression
Carla Carnovale et al.
PSYCHOLOGICAL MEDICINE (2022)
How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice
Stephen M. Stahl et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
Using propensity scores to estimate effects of treatment initiation decisions: State of the science
Michael Webster-Clark et al.
STATISTICS IN MEDICINE (2021)
Association of Low-Dose Quetiapine and Diabetes
Mikkel Hojlund et al.
JAMA NETWORK OPEN (2021)
Use of antipsychotics in Denmark 1997-2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses
M. Hojlund et al.
EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2021)
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2019)
Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
Mikkel Hojlund et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Rishi J. Desai et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Data Resource Profile: The Danish National Prescription Registry
Anton Pottegard et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Oskar Halfdanarson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review
Marco Solmi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll et al.
WORLD PSYCHIATRY (2015)
Association of Selected Antipsychotic Agents With Major Adverse Cardiovascular Events and Noncardiovascular Mortality in Elderly Persons
Marie Sahlberg et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
Marc De Hert et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
Sebastian Schneeweiss et al.
EPIDEMIOLOGY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)